Trial Outcomes & Findings for Skin Incision Adhesive in Pediatrics (NCT NCT01514396)

Results Overview

wound closure measured baseline to 14 days

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

8 participants

Primary outcome timeframe

baseline to 14 days

Results posted on

2018-12-04

Participant milestones
Measure	Surgical Glue Surgiseal Surgiseal: surgical glue To determine if SurgiSeal™ can effectively seal epidermal wounds in children while not causing any adverse events.
Overall Study STARTED	8
Overall Study COMPLETED	8
Overall Study NOT COMPLETED	0

Withdrawal data not reported

Skin Incision Adhesive in Pediatrics

Baseline characteristics by cohort
Measure	Surgical Glue n=8 Participants Surgiseal Surgiseal: surgical glue
Age, Categorical <=18 years	8 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	0 Participants n=5 Participants
Age, Categorical >=65 years	0 Participants n=5 Participants
Sex: Female, Male Female	2 Participants n=5 Participants
Sex: Female, Male Male	6 Participants n=5 Participants
Region of Enrollment United States	8 participants n=5 Participants

Timeframe: baseline to 14 days

wound closure measured baseline to 14 days

Outcome measures
Measure	Wound Closure n=8 Participants Number of Participants with Wound Closure baseline to 14 days from discharge
Number of Participants With Wound Closure	8 participants

Timeframe: 14 days

Adverse events reported

Outcome measures
Measure	Wound Closure n=8 Participants Number of Participants with Wound Closure baseline to 14 days from discharge
Adverse Events Related to Wound Closure	0 participants

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

Medline Industries, Inc.

Phone: 847-643-3874